Skip to content

The Impact of Perioperative Transcutaneous Electrical Acupoint Stimulation on Postoperative Anxiety in Surgical Patients: A Prospective Multicenter Randomized Controlled Trial

The Impact of Perioperative Transcutaneous Electrical Acupoint Stimulation on Postoperative Anxiety in Surgical Patients: A Prospective Multicenter Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000195
Enrollment
Unknown
Registered
2025-01-26
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety

Interventions

sham-TEAS group:The same acupoints and intervention time points as those in the TEAS group were selected and the placebo treatment was given that is only electrode pads were attached without electrica
TEAS group:Bilateral Neiguan (PC 6) and bilateral Shenmen (HT 7) points were selected before during and after operation respectively. A 4/20Hz disperse-dense wave was selected and lasted for 30min eac

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years old both sexes; 2) ASA grade I-III; 3) 18kg/m2=BMI=30 kg/m2; 4) patients who planned to undergo elective surgery under general anesthesia (mainly gastrointestinal surgery); the operation time > 2 hours; 5) fully understand and voluntarily participate in this trail and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with any of the following could not be enrolled in this trail 1) ASA>III; 2) patients undergoing epidural anesthesia; 3) intraoperative and postoperative complications requiring long-term intensive care (> 1 day); 4) Allergic or contraindicated to opioids propofol or other drugs or their drug components; 5) patients with acute heart failure unstable angina pectoris myocardial infarction within the past 6 months pacemaker or other metallic implants; 6) patients who received TEAS or acupuncture within 1 month before the trial; 7) patients with severe coagulation dysfunction; 8) patients with diagnosed anxiety or depression; 9) patients with other mental diseases long-term use of psychotropic drugs or cognitive impairment; 10) pregnant or lactating women; 11) poor compliance and failure to complete the trial according to the study protocol; 12) participants who participated in clinical trials of other drugs within the past 4 weeks; 13) there were any circumstances deemed unsuitable for inclusion by the investigator for any reason.

Design outcomes

Primary

MeasureTime frame
Anxiety;

Secondary

MeasureTime frame
rScO2;Time to extubation;Gender age height weight and ASA classification;Anesthesia induction time tracheal intubation time operation time end of anesthesia time;Pain level;Quality of postoperative recovery;Sleep Quality;cTNT H-FABP;Length of stay;The frequency of nausea and vomiting;Recovery score;Vital signs monitoring (ECG HR BP SpO2 BIS);The total amount and infusion time of propofol and remifentanil used during operation;

Countries

China

Contacts

Public ContactYu YonghaoLi QingWang Chunyan

Department of Anesthesiology Tianjin Medical University General Hospital

yuyonghao@126.com13920590099

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026